• About
  • Services
  • Profiles
  • News
  • Contact

    RMMS Secures Favorable Claim Construction Ruling In Suit Involving Generic Aripiprazole (Abilify®) -
    RMMS Recognized as Industry Leaders by LMG Life Sciences for Fourth Consecutive Year -
    RMMS Secures Summary Judgment Against Otsuka Related To Generic Aripiprazole (Abilify®) -
    Federal Circuit Affirms Judgment of Invalidity Concerning Pulmicort Respules® (budesonide inhalation suspension) -
    RMMS Secures Second Victory Against Otsuka Related To Generic Aripiprazole (Abilify®) -
    Chief Judge Simandle Allows Launch of Generic Aripiprazole (Abilify®) -
    Federal Circuit Affirms Invalidity Judgment Concerning Zymaxid®/Zymar® (Gatifloxacin) Ophthalmic Solutions -
    RMMS Files Supreme Court Amicus Brief on Behalf of GPhA Supporting Specific-Intent-to-Infringe Requirement for Induced Infringement -
    RMMS Secures Judgment of Patent Invalidity Following Remand Trial Involving Generic Pulmicort Respules® (Budesonide Inhalation Suspension) -
    Federal Circuit Affirms Judgment Of Non-Infringement Involving Generic Trizivir® (Abacavir Sulfate, Lamivudine, and Zidovudine) Tablets -
    • About
    • Services
    • Profiles
    • News
    • Contact
    • Disclaimers
    • Copyright © 2022 Rakoczy Molino Mazzochi Siwik LLP